Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

I think you are really asking two questions...

1) How good is the data release?

A: After reading analysis by others who are much more informed about the scientific details than I am, it appears the data is promising, but inconclusive. There is no home run in the data, but there's nothing bad about it either. I think what is more important was the proof that the company is moving forward with its research. Now proven, we will need more studies and more data. The problem there is Provectus has always been extraordinarily slow in producing data, and studies cost money, of which Provectus has none. So this alone is not taking us to the moon; now that we had our little bump, its effect on pps is neutral.

2) So where is the pps going?

A: Since the mojo from the news has now run its course, pps is at the mercy of technical indicators. Most technical indicators suggest a pullback is coming. PVCT might need to test .04 support, and if it fails (it might) then it will test .033 again. However, I think any pullback will be much milder than the last one; those who recently bought in are not as likely to sell. A month ago, it was unclear if the company was even doing business or not, and shareholders were getting antsy.

So: I think we will need more news to take this out of the .03-.04 range. This news probably will keep us out of the .02's.

All of this is imho, and I would be happy to be wrong and see a four bagger tomorrow. But I think we will need to stay patient...


Data explained here: http://www.trustintelligence.com/forum/viewtopic.php?pid=151312#p151312

Also good discussion here:

https://www.investorvillage.com/smbd.asp?mb=4121&pt=m